Sichuan hot pots, vindaloo pork, tom yum soup, bibimbap with kimchi, cochinita pibil tacos, “suicide” Buffalo wings…
As far as spicy food goes, I’ve tried nearly all of it… and loved most of it.
My daughters, when they were young – not so much.
So, when I finally got fed up with their spice avoidance, I decided to employ some Greek military tactics.
No, not a phalanx… but the Trojan Horse.
I’d add just a tiny bit of spice into their favorite foods – a couple of red pepper flakes on a slice of pizza… a sprinkle of hot sauce into a pot of macaroni of cheese – and then upped the spice levels over a few weeks until they were actually enjoying it.
They may not have been ready for ghost peppers yet – but the problem was essentially solved.
Tech companies also use this tactic…
And right now, the biggest fad of 2016 is introducing us all to an emerging technology that’s on track to become a $150 billion-a-year business by the time this decade is over.
That fad is Pokémon Go.
And that “Trojan Horse” technology is the subject of today’s report.
I’ll show you how this technology is already making a fortune for early investors.
And I’ll point you to the company that’s best poised to take this technology and run with it.
The F-35B stealth fighter from Lockheed Martin Corp. wowed the crowd in its British debut. The ultra-sleek aircraft not only hovered but also turned 360 degrees.
Then there was 737 MAX from Boeing Co. (NYSE: BA). The huge passenger jet, showing off for the first time for an international audience, accomplished an incredible near-vertical takeoff before leveling off and plunging… all on purpose.
Then there were the always hotly watched “backroom deals” – in which Airbus Group SE racked up orders and commitments for 279 planes worth $35 billion, while Boeing brought in orders and commitments for 182 airplanes worth $26.8 billion.
I’m talking about the Farnborough International Airshow, which took place about a week ago near the southern coast of England.
It’s a signature industry meeting in which commercial aerospace and defense firms pile up big sales.
But those stories above are about “old aviation.”
As amazing as some of those aeronautical feats and big-number deals were, the real story at Farnborough involved a fleet of 90 highly advanced tiny fliers.
They truly knocked my socks off, because they point right to the future of a $55 billion industry.
Today I’ll show you how to play this red-hot trend for big tech profits now – and in the long term…
Some may still be bemoaning the sideways market we’ve seen for the past 18 months. But with all that’s going on in the world, Michael likes it just fine – and he appeared on CNBC World Wednesday to explain why.
Plus, he reveals a stock to look at… and another to avoid. And he lets us know what to expect through the end of the year.
Veteran sailors and tech investors have one important quality in common.
They understand how to navigate choppy conditions.
That shared insight is something I know about firsthand. You see, I’ve been racing sailboats and covering Silicon Valley for close to 35 years.
In recent years, I even found a way to combine those two loves: Though I eventually traded the rigors of racing for the simple joys of cruising, I now manage to go sailing on a regular basis with a couple of tech-investing pros – including one who’s a daily denizen of “the Valley.”
During one outing, we traded stories about battling whipping winds and four-foot-and-higher waves. And we talked about the market.
And here’s what we all agreed on: Despite the Dow Jones Industrial Average and S&P 500 Index reaching record highs last week, the choppy seas we’ve seen in the markets for the past 18 months will continue for at least the near future.
But that doesn’t mean you should stay tied up at the dock.
Our goal here is to show you how to build wealth using tech investments.
A doctor injects a “corrective” gene into a virus. Then he uses that virus to introduce the new gene and modified DNA into a patient’s diseased cells. If the treatment is successful, the cells’ gene-reading machinery will build RNA messengers and protein molecules – i.e., disease fighters.
It’s a process that could be a cure for hundreds of genetic-related diseases.
That’s gene therapy in action.
When biotech researchers get gene therapy to work dependably, it will be a boon for humanity – and for investors.
For decades, Big Pharma has run on the same basic plan – use chemicals to create disease-fighting drugs. However, many of the drugs they end up creating carry severe side effects or are highly addictive.
But now, after a quarter century of failed experiments and numerous setbacks, gene therapy finally has the potential to make patients well again without addictive or harmful drugs.
Researchers worldwide report successful gene-therapy trials – and new and innovative uses for the technology – seemingly every week. The first federally approved gene therapy, the severe pancreatitis treatment Glybera, hit the market in late 2014 as. And I think the next half decade will bring dozens more gene-therapy products along those same lines.
Now, finding a way to invest in this newly disruptive biotechnology is tough. Most of the companies working on gene therapies are privately held or very risky, illiquid clinical-stage biotech companies that I just can’t recommend to beginning investors.
However, I have located a great backend way to play this breakthrough field. Its stock has soared 25% in just the past five months or so – and it shows no sign of slowing down. Plus, it pays a healthy 2% dividend.
We may be looking a solid times in the markets, but Michael says that the last thing you want to do right now is sell. During his latest appearance on Fox Business, on Cavuto: Coast to Coast, Michael explains that people have been betting against the stock market for years, and they’ve been proven time and time again. That is… unless they focus on one simple thing.
Throughout this long “flat” market, Wall Street has lurched from crisis to crisis. Retail investors “panic sell” first and get the facts later… if ever.
And the big shots on Wall Street clean up – a rigged system.
Nowhere was that more clear than the sell-off we saw after the June 23 Brexit vote.
It was a “crisis.” And sure enough, stocks sold off for two days.
But then they went on to rally with great fervor – and they’re now hovering around record highs.
I guarantee you that during this stretch plenty of Main Street investors lost a bundle while Wall Street firms lined their own pockets.
That’s why, when I tell you the best way to get rich is to invest in tech, I don’t look at the day-to-day lurches in the stock market. Instead, I turn to the strength of our economy.
That’s what is going to drive the stocks you hold higher in the long run… not this or that momentary “crisis.”
And here in the United States, we’re seeing some pretty upbeat economic reports…
In Friday’s jobs report, the U.S. Labor Department said nonfarm payrolls rose by a seasonally adjusted 287,000 – the strongest month of hiring since last October.
Last month, the National Association of Realtors said sales of existing homes in May, the last month for full data, increased 1.8% to an annual rate of 5.53 million units. That’s the highest level since February 2007.
Analysts at Autodata said car and truck sales in June came in at a seasonally adjusted annual rate of 16.6 million units. That’s a bit below forecast but follows record sales for 2015 and a 17.5 million run rate in May.
And a few weeks ago, the early numbers from the U.S. Commerce Department showed the economy had grown at a mere 0.5% in the first quarter. That’s slow growth, but those numbers have been upgraded twice since then. And the first-quarter GDP now looks to have expanded by 1%.
That’s all good news for the U.S. economy.
But for tech investors like you, the news is even better…
Big-cap investors were profoundly underwhelmed when the Obama administration forced the cancellation of a Big Pharma player’s $150 billion buyout of another massive biopharmaceutical company.
Like most deal-making at this level, there was a lot at stake. The company that was to be acquired has a portfolio packed with name-brand drugs with long patent lives and a robust generics business. What’s more, the deal would have allowed the prospective buyer to relocate its headquarters to (extremely) tax-friendly Ireland and save a ton on payments to Uncle Sam.
Normally when a deal like this falls through, the wannabe buyer’s shares take a serious pounding, but the smart money is holding its nerve. In fact, its stock is up just over 10% year to date.
That says a lot.
Those investors, along with folks who buy in right now, stand to be richly rewarded in the future.
That’s because there’s something bigger – much bigger – than that $150 billion deal coming down the road.
The market for technology initial public offerings is “awful”… 2016 has been a “terrible” year for tech IPOs… the whole sector for tech IPOs is “frozen over.”
I’ve been hearing all that – and much worse – from the Wall Street press.
So have you.
And it’s true to an extent. Thanks to a slow Chinese economy and low oil prices, zero tech companies went public on American stock exchanges in the first quarter.
That’s why the successful June 23 IPO of Twilio Inc. (NYSE: TWLO) is so important.
Silicon Valley and its investors love nothing more than a successful IPO.
Shares of Twilio – which develops and operates cloud-based messaging platforms – nearly doubled on the opening day from their original price of $15. Over the next five sessions, they rose another 29%… to $37.
And Twilio’s success is far from the only evidence of a tech IPO rebound. I’ll show you some of that in today’s report.
Plus, I’ll reveal the one best way to play the reopening of the “IPO window.”
Over the past five years, it has returned more than 96% to investors, compared to 58% for the S&P 500. And that makes it an investment you can count on for the long haul.